CC BY 4.0 · Rev Bras Ginecol Obstet 2019; 41(09): 525-530
DOI: 10.1055/s-0039-1696948
Original Article
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Progesterone's Serum Level and a New Ultrasonographic Parameter in the First Trimester Pregnancy – Prognostic Factors for Embryonic Demise

1   Department of Obstetrics and Gynecology, University of Medicine and Pharmacy “Iuliu Haţieganu”, Cluj-Napoca, Romania.
,
Razvan Ciortea
1   Department of Obstetrics and Gynecology, University of Medicine and Pharmacy “Iuliu Haţieganu”, Cluj-Napoca, Romania.
,
Andrei Mihai Malutan
1   Department of Obstetrics and Gynecology, University of Medicine and Pharmacy “Iuliu Haţieganu”, Cluj-Napoca, Romania.
,
Costin Berceanu
2   Department of Obstetrics and Gynecology, University of Medicine and Pharmacy of Craiova, Craiova, Romania
,
Maria Patricia Rada
1   Department of Obstetrics and Gynecology, University of Medicine and Pharmacy “Iuliu Haţieganu”, Cluj-Napoca, Romania.
,
Dan Mihu
1   Department of Obstetrics and Gynecology, University of Medicine and Pharmacy “Iuliu Haţieganu”, Cluj-Napoca, Romania.
› Institutsangaben
Weitere Informationen

Publikationsverlauf

20. November 2018

15. Juli 2019

Publikationsdatum:
23. September 2019 (online)

Abstract

Objective The etiology of embryonic demise is multifactorial, with chromosomal abnormalities being the most common (40%). The purpose of the present study is to evaluate the correlation between a serum biomarker, progesterone, and an ultrasonographic parameter, the distance between yolk sac and embryo (DYSE) in assessing the prognosis of pregnancy outcome in the 1st trimester.

Methods The present study is a prospective case-control analysis that includes 2 groups of patients: 81 patients with first-trimester normal evolutive pregnancy and 89 patients with embryonic demise, all of the patients having between 6 and 11 weeks of amenorrhea. Endovaginal ultrasonographic exploration was performed to evaluate the distance between the lower pole of the embryo and the yolk sac. From each subject enrolled in the study, 20 ml of blood was collected for progesterone serum level measurement.

Results Regarding the DYSE in the case group, lower values were observed compared with the control group, the difference being statistically significant. In the statistical analysis of serum progesterone values, statistically significant differences were observed between the 2 groups (p < 0.05).

Conclusion The DYSE has a high positive predictive value in identifying pregnancies with potentially reserved outcome, with the present study demonstrating that a DYSE < 3 mm causes an unfavorable evolution of the pregnancy. Low serum levels of progesterone are associated with an increased rate of nonviable embryos. The correlation between these two parameters increases the effectiveness of screening methods in prenatal monitoring and improves the diagnostic methods for the first-trimester pregnancies whose outcome potential can be reserved.

Contributors

All of the authors contributed with the project and data interpretation, the writing of the article, the critical review of the intellectual content, and with the final approval of the version to be published.


 
  • References

  • 1 Elson J, Salim R, Tailor A, Banerjee S, Zosmer N, Jurkovic D. Prediction of early pregnancy viability in the absence of an ultrasonically detectable embryo. Ultrasound Obstet Gynecol 2003; 21 (01) 57-61 . Doi: 10.1002/uog.1
  • 2 Azmanov DN, Milachich TV, Zaharieva BM. , et al. Profile of chromosomal aberrations in different gestational age spontaneous abortions detected by comparative genomic hybridization. Eur J Obstet Gynecol Reprod Biol 2007; 131 (02) 127-131 . Doi: 10.1016/j.ejogrb.2006.04.037
  • 3 Jauniaux E, Johns J, Burton GJ. The role of ultrasound imaging in diagnosing and investigating early pregnancy failure. Ultrasound Obstet Gynecol 2005; 25 (06) 613-624 . Doi: 10.1002/uog.1892
  • 4 Woods-Giscombé CL, Lobel M, Crandell JL. The impact of miscarriage and parity on patterns of maternal distress in pregnancy. Res Nurs Health 2010; 33 (04) 316-328 . Doi: 10.1002/nur.20389
  • 5 Bourdiec A, Shao R, Rao CV, Akoum A. Human chorionic gonadotropin triggers angiogenesis via the modulation of endometrial stromal cell responsiveness to interleukin 1: a new possible mechanism underlying embryo implantation. Biol Reprod 2012; 87 (03) 66 . Doi: 10.1095/biolreprod.112.100370
  • 6 Hanita O, Hanisah AH. Potential use of single measurement of serum progesterone in detecting early pregnancy failure. Malays J Pathol 2012; 34 (01) 41-46
  • 7 Abdelazim IA, Elezz AA, Elsherbiny M. Relation between single serum progesterone assay and viability of the first trimester pregnancy. Springerplus 2012; 1 (01) 80 . Doi: 10.1186/2193-1801-1-80
  • 8 Vicdan K, Zeki Isik A. Luteal phase hormonal profile in prediction of pregnancy outcome after assisted reproduction. Eur J Obstet Gynecol Reprod Biol 2001; 96 (01) 98-101 . Doi: 10.1016/S0301-2115(00)00400-0
  • 9 Al Jufairi ZAA. The value of serum progesterone measurement in early pregnancy. Bahrain Med Bull 2000; 22 (01) 1-6
  • 10 Phipps MG, Hogan JW, Peipert JF, Lambert-Messerlian GM, Canick JA, Seifer DB. Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnancies. Obstet Gynecol 2000; 95 (02) 227-231 . Doi: 10.1016/S0029-7844(99)00480-9
  • 11 Royal College of Obstetricians and Gynaecologists. Management of Early Pregnancy Loss. London: RCOG Press; 2006
  • 12 Filly MR, Callen PW, Yegul NT, Filly RA. The yolk stalk sign: evidence of death in small embryos without heartbeats. J Ultrasound Med 2010; 29 (02) 237-241 . Doi: 10.7863/jum.2010.29.2.237
  • 13 Aziz S, Cho RC, Baker DB, Chhor C, Filly RA. Five-millimeter and smaller embryos without embryonic cardiac activity: outcomes in women with vaginal bleeding. J Ultrasound Med 2008; 27 (11) 1559-1561 . Doi: 10.7863/jum.2008.27.11.1559
  • 14 Rowling SE, Langer JE, Coleman BG, Nisenbaum HL, Horii SC, Arger PH. Sonography during early pregnancy: dependence of threshold and discriminatory values on transvaginal transducer frequency. AJR Am J Roentgenol 1999; 172 (04) 983-988 . Doi: 10.2214/ajr.172.4.10587132
  • 15 Laing FC, Frates MC, Benson CB. Ultrasound evaluation during the first trimester of pregnancy. In: Callen PW. , ed. Ultrasonography in Obstetrics and Gynecology. 5th ed. Philadelphia, PA: Saunders Elsevier; 2008: 181-224
  • 16 Aisemberg J, Vercelli CA, Bariani MV, Billi SC, Wolfson ML, Franchi AM. Progesterone is essential for protecting against LPS-induced pregnancy loss. LIF as a potential mediator of the anti-inflammatory effect of progesterone. PLoS One 2013; 8 (02) e56161 . Doi: 10.1371/journal.pone.0056161
  • 17 Daily CA, Laurent SL, Nunley Jr WC. The prognostic value of serum progesterone and quantitative beta-human chorionic gonadotropin in early human pregnancy. Am J Obstet Gynecol 1994; 171 (02) 380-383, discussion 383–384 . Doi: 10.1016/s0002-9378(94)70038-9
  • 18 Taghavi AH. Detection of changes of hCG, progesterone and estradiol serum levels in threatened abortion in the first three months of gestation. Majallah-i Ghudad-i Darun/Riz va Mitabulism-i Iran 2004; 6: 163-169
  • 19 al-Sebai MA, Kingsland CR, Diver M, Hipkin L, McFadyen IR. The role of a single progesterone measurement in the diagnosis of early pregnancy failure and the prognosis of fetal viability. Br J Obstet Gynaecol 1995; 102 (05) 364-369 . Doi: 10.1111/j.1471-0528.1995.tb11286.x
  • 20 Mol BW, Lijmer JG, Ankum WM, van der Veen F, Bossuyt PM. The accuracy of single serum progesterone measurement in the diagnosis of ectopic pregnancy: a meta-analysis. Hum Reprod 1998; 13 (11) 3220-3227 . Doi: 10.1093/humrep/13.11.3220
  • 21 Salamanca A, Fernández-Salmerón P, Beltrán E, Mendoza N, Florido J, Mozas J. Early embryonic morphology sonographically assessed and its correlation with yolk sac in missed abortion. Arch Gynecol Obstet 2013; 287 (01) 139-142 . Doi: 10.1007/s00404-012-2499-8
  • 22 Duan L, Yan D, Zeng W, Yang X, Wei Q. Predictive power progesterone combined with beta human chorionic gonadotropin measurements in the outcome of threatened miscarriage. Arch Gynecol Obstet 2011; 283 (03) 431-435 . Doi: 10.1007/s00404-010-1367-7